Phytotherapic compounds against coronaviruses: Possible streams for future research
- 9 May 2020
- journal article
- letter
- Published by Wiley in Phytotherapy Research
- Vol. 34 (7), 1469-1470
- https://doi.org/10.1002/ptr.6712
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Can Chinese Medicine Be Used for Prevention of Corona Virus Disease 2019 (COVID-19)? A Review of Historical Classics, Research Evidence and Current Prevention ProgramsChinese Journal of Integrated Medicine, 2020
- Therapeutic options for the 2019 novel coronavirus (2019-nCoV)Nature Reviews Drug Discovery, 2020
- Antiviral activity of Sambucus FormosanaNakai ethanol extract and related phenolic acid constituents against human coronavirus NL63Virus Research, 2019
- Black elderberry (Sambucus nigra) supplementation effectively treats upper respiratory symptoms: A meta-analysis of randomized, controlled clinical trialsComplementary Therapies in Medicine, 2018
- Chinese herbs combined with Western medicine for severe acute respiratory syndrome (SARS)Emergencias, 2012
- Investigation of the influence of EPs® 7630, a herbal drug preparation from Pelargonium sidoides, on replication of a broad panel of respiratory virusesPhytomedicine, 2010
- Cistus incanus (CYSTUS052) for treating patients with infection of the upper respiratory tract: A prospective, randomised, placebo-controlled clinical studyAntiviral Research, 2009
- Pelargonium sidoides for acute bronchitis: A systematic review and meta-analysisPhytomedicine, 2008
- In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compoundsJournal of Clinical Virology, 2004
- Immune System Effects of Echinacea, Ginseng, and Astragalus: A ReviewIntegrative Cancer Therapies, 2003